# FDA recall D-0266-2023

> **McGuff Compounding Pharmacy Services, Inc.** · Class II · drug recall initiated 2022-12-08.

## Product

Thiamine Hydrochloride 200 mg/2mL (100mg/mL), Riboflavin 2 mg/2mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 2 mL Sterile Single Use Vial, Preservative-Free, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704.

## Reason for recall

Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0266-2023
- **Recalling firm:** McGuff Compounding Pharmacy Services, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-08
- **Report date:** 2023-02-22
- **Termination date:** 2023-04-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Santa Ana, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0266-2023

## Citation

> AI Analytics. FDA recall D-0266-2023. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0266-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*